scispace - formally typeset
S

Sachin Mulik

Researcher at Boston Children's Hospital

Publications -  34
Citations -  1269

Sachin Mulik is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Cytotoxic T cell & Corneal neovascularization. The author has an hindex of 16, co-authored 30 publications receiving 996 citations. Previous affiliations of Sachin Mulik include Harvard University & University of Texas Health Science Center at Tyler.

Papers
More filters
Journal ArticleDOI

Cytotoxic Cells Kill Intracellular Bacteria through Granulysin-Mediated Delivery of Granzymes

TL;DR: Mice expressing transgenic granulysin are better able to clear Listeria monocytogenes and play an unexpected role in bacterial defense, suggesting that granzymes disrupt multiple vital bacterial pathways.
Journal ArticleDOI

Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites

TL;DR: GNLY-transgenic mice are protected against infection by T. cruzi and T. gondii, and survive infections that are lethal to wild-type mice, and GNLY, PFN- and Gzm-mediated elimination of intracellular protozoan parasites is an unappreciated immune defense mechanism.
Journal ArticleDOI

Controlling Herpes Simplex Virus-Induced Ocular Inflammatory Lesions with the Lipid-Derived Mediator Resolvin E1

TL;DR: These findings are, to the authors' knowledge, the first to show that RvE1 treatment could represent a novel approach to control lesion severity in a virally induced immunopathological disease.
Journal ArticleDOI

Decidual NK Cells Transfer Granulysin to Selectively Kill Bacteria in Trophoblasts

TL;DR: It is shown that human dNK cells highly express the antimicrobial peptide granulysin (GNLY) and selectively transfer it via nanotubes to extravillous trophoblasts to kill intracellular Listeria monocytogenes (Lm) without killing the trophoblast.
Journal ArticleDOI

Role of miR-132 in Angiogenesis after Ocular Infection with Herpes Simplex Virus

TL;DR: This study shows that miR-132 expression was up-regulated after ocular infection with HSV, an event that involved the production of both VEGF-A and IL-17, and holds promise as a therapeutic approach to control an ocular lesion that is an important cause of human blindness.